Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company ViroMed Co. Ltd.
DescriptionAnti-tumor vaccine containing naked DNA vector encoding engineered HER2/neu gene
Molecular Target Epidermal growth factor receptor 2 (HER2) (EGFR2) (ErbB2) (neu)
Mechanism of ActionGene therapy; Vaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I
Standard IndicationBreast cancer
Indication DetailsTreat and prevent breast cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today